The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.
A new issue brief shows where Americans typically get flu vaccines in the U.S. and how much it costs to administer flu and other vaccines.
People with medical conditions that put them at higher risk of developing serious COVID-19 illness are next in line to get vaccinated in many states, though states are making very different choices about how to prioritize those within this large group, finds a KFF analysis of state policies.
During the 55th week since the first coronavirus case appeared in the United States, the world is at nearly 108 million COVID-19 cases. The U.S. approached 27.4 million cases and a total of 475,400 deaths.
In the January report from the COVID-19 Vaccine Monitor, the lack of information around where and when to get the COVID-19 vaccine is particularly pronounced among Hispanic and Black adults compared to White Adults. Learn more in this Chart of the Week.
In his latest Axios column, Drew Altman shows why vaccine hesitancy will naturally decrease as more and more people see their family members and friends vaccinated without adverse consequences. It’s a hopeful sign about vaccine hesitancy, and should help free up resources to focus on the remaining vaccine hesitant.
We examine the Biden administration’s proposal to partner with community health centers to speed up vaccinations, especially in hard-to-reach populations.
This report summarizes the public’s response to a series of open-ended questions aimed at better understanding people’s concerns around receiving a COVID-19 vaccine and the views of the messages and messengers that could affect their willingness to get one,
With the COVID-19 vaccination rollout still in its early stages, a KFF analysis finds that most older adults have not yet been vaccinated against the potentially deadly virus, as vaccine supplies remain limited and most states have only recently begun to make people 65 and older eligible.
This analysis looks at vaccination rates among older adults at the state level, and the share of all vaccines administered that have been given to older adults, among states reporting vaccination data by age.
© 2025 KFF